$138 Million is the total value of New Leaf Venture Partners, L.L.C.'s 17 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 31.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARVN | ARVINAS INC | $44,114,513 | -23.1% | 1,289,521 | 0.0% | 31.94% | -6.2% | |
| Buy | RALLYBIO CORPORATION | $21,691,532 | -34.9% | 3,301,603 | +43.4% | 15.70% | -20.5% | |
| DCPH | DECIPHERA PHARMACEUTICALS INC | $19,824,869 | -11.4% | 1,209,571 | 0.0% | 14.35% | +8.1% | |
| EWTX | EDGEWISE THERAPEUTICS INC | $13,889,729 | -9.1% | 1,553,661 | 0.0% | 10.06% | +10.8% | |
| Sell | DICE THERAPEUTICS INC | $11,596,822 | +2.7% | 371,693 | -33.2% | 8.40% | +25.3% | |
| COGT | COGENT BIOSCIENCES INC. | $5,797,687 | -22.5% | 501,530 | 0.0% | 4.20% | -5.5% | |
| PASG | PASSAGE BIO | $3,447,132 | +10.4% | 2,497,922 | 0.0% | 2.50% | +34.8% | |
| AMYT | AMRYT PHARMA PLCsponsored ads | $3,283,080 | +5.5% | 449,737 | 0.0% | 2.38% | +28.8% | |
| ALEC | ALECTOR INC | $3,134,222 | -2.4% | 339,569 | 0.0% | 2.27% | +19.0% | |
| CRNX | CRINETICS PHARMACEUTICALS INC | $2,580,300 | -6.8% | 141,000 | 0.0% | 1.87% | +13.7% | |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $2,313,996 | – | 118,242 | +100.0% | 1.68% | – |
| HARP | HARPOON THERAPEUTICS INC | $2,290,816 | -25.2% | 3,156,699 | 0.0% | 1.66% | -8.8% | |
| CMRX | CHIMERIX INC | $2,277,756 | -3.6% | 1,224,600 | 0.0% | 1.65% | +17.6% | |
| ARAV | ARAVIVE INC | $1,249,278 | +61.6% | 946,423 | 0.0% | 0.90% | +96.9% | |
| XFOR | X4 PHARMACEUTICALS INC | $332,655 | -41.9% | 335,000 | 0.0% | 0.24% | -29.1% | |
| AVRO | AVROBIO INC | $224,956 | +10.8% | 315,550 | 0.0% | 0.16% | +35.8% | |
| New | ITERUM THERAPEUTICS PLC | $81,551 | – | 97,084 | +100.0% | 0.06% | – | |
| ADXN | Exit | ADDEX THERAPEUTICS LTDsponsored ads | $0 | – | -50,000 | -100.0% | -0.02% | – |
| ITRM | Exit | ITERUM THERAPEUTICS PLC | $0 | – | -97,084 | -100.0% | -0.09% | – |
| PDSB | Exit | PDS BIOTECHNOLOGY CORP | $0 | – | -117,242 | -100.0% | -0.21% | – |
| Exit | RENOVACOR CORPORATION | $0 | – | -670,689 | -100.0% | -1.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-06
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DECIPHERA THERAPEUTICS INC | 25 | Q3 2023 | 44.4% |
| CHIMERIX INC | 25 | Q1 2023 | 20.9% |
| SIERRA ONCOLOGY INC | 22 | Q2 2022 | 14.9% |
| ARVINAS INC | 21 | Q3 2023 | 44.8% |
| CRINETICS PHARMACEUTICALS INC | 21 | Q3 2023 | 11.4% |
| OBSEVA SA | 20 | Q4 2021 | 8.5% |
| AVROBIO INC | 20 | Q1 2023 | 1.7% |
| HARPOON THERAPEUTICS INC | 19 | Q3 2023 | 20.0% |
| ALECTOR INC | 19 | Q3 2023 | 4.6% |
| ITERUM THERAPEUTICS PLC | 18 | Q3 2022 | 3.8% |
View New Leaf Venture Partners, L.L.C.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-06 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-09 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
View New Leaf Venture Partners, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.